Davis Polk Advises PepsiCo, Inc. on Its $2.5 Billion Notes Offering

Davis Polk advised PepsiCo, Inc. on its registered offering of $900 million aggregate principal amount of 0.7% senior notes due 2015, $1 billion aggregate principal amount of 1.25% senior notes due 2017 and $600 million aggregate principal amount of 3.6% senior notes due 2042. Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and RBS Securities Inc. acted as joint book-running managers for the offering.

More >>

Tags:  Davis Polk & Wardwell | New York

Herbert Smith and HBT Advise Credit Suisse and Deutsche Bank on US$74 Million Treasury Share Sale by Bank Central Asia

Herbert Smith and its associated Indonesian law firm Hiswara Bunjamin & Tandjung (HBT) have advised Credit Suisse and Deutsche Bank as placing agents in connection with the offering and sale of treasury shares in PT Bank Central Asia Tbk, an Indonesian retail and commercial bank listed on the Indonesia Stock Exchange.

More >>

Tags:  Herbert Smith Freehills LLP | Singapore

Simpson Thacher Represents hiSoft Technology International Limited in its Proposed Merger with VanceInfo Technologies Inc.

The Firm is representing hiSoft Technology International Limited (“hiSoft”) in connection with its proposed merger with VanceInfo Technologies Inc. (“VanceInfo”). Under the terms of the merger agreement, the companies will be combined in a tax-free, all-stock merger of equals with a combined equity value of approximately US$875 million. VanceInfo and hiSoft shareholders will each own approximately 50% of the combined company. The combined company will continue to be traded on the NASDAQ as hiSoft shares.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Hong Kong

Simpson Thacher Represents The Carlyle Group in Acquisition of TCW

Simpson Thacher is representing affiliates of The Carlyle Group in connection with their acquisition of The TCW Group, Inc. (“TCW”) from Société Générale. Founded in 1971, TCW is a Los Angeles-based diversified asset management firm offering U.S. equities and fixed income, international and alternative strategies, with approximately $130 billion under management. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2013. Financial terms were not disclosed.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Shearman & Sterling Advises Sun Pharmaceutical on Merger with Taro Pharmaceutical

Shearman & Sterling is advising Sun Pharmaceutical Industries Ltd. (Sun Pharma) on its merger agreement with Taro Pharmaceutical Industries Ltd. (Taro). Upon completion of the merger, Taro will become a privately held company, will be wholly owned by affiliates of Sun Pharma, and its ordinary shares will no longer be traded on the New York Stock Exchange. The closing of the merger is subject to certain terms and conditions customary for transactions of this type.

More >>

Tags:  Shearman & Sterling LLP | New York